Other Headlines
Have News for Us?
Submit your news on the industry, people, or companies.
Forward to a FriendMore Industry Headlines
ACR Lines Up to Accredit Imaging Centers Under New CMS Rules The American College of Radiology announced it will be among the first to apply for authority to accredit freestanding diagnostic imaging centers as required by new CMS rules.
Swine Flu Resources Get helpful sites and dashboards to track the spread of the disease and access health information and services.
Shock Wave Therapy Helps Bones Mend Broken long bones that aren't healing could be patched up by shock waves.
Freestanding Imaging Centers Slammed by CMS Ruling The announcement of the final rules by CMS, believed to slash imaging reimbursements by 16 percent, could result in mass closings of rural clinics, according to the American College of Radiology.
Analysts See Big Growth in Devices That Make Home Treatments Easier Needle-less, pain-free and home drug delivery devices to show growth in the parenteral market, according to analysts.
Researchers Check Suspicious Looking Mole (Rat) Pint-sized creature proves an interesting riddle.
FTC Extends Enforcement Deadline for Red Flags Rule Enforcement is scheduled to begin June 2010.
Rad Groups Recommend Keeping a Closer Eye on CT Scan Dosage Protocols After Cedars-Sinai Fiasco In the wake of accidental radiation overexposure of hundreds of patients at a Los Angeles hospital, two leading radiologists groups offer guidelines for making sure patients are getting safe scans.
Stereotactic Radiotherapy Halts Lung Cancer in Patients Too Sick for Surgery A recent study presented at this year's ASTRO annual meeting shows that stereotactic body radiation therapy (SBRT) can kill lung cancer tumors and keep them from recurring in medically frail patients ineligible for surgery.
Health Care Reform Round-Up: GOP Releases Health Care Plan; CBO Analyzes House Bill H.R. 3962 estimated to cost $894 billion, reduce budget deficit by $104 billion.
brings advanced technology
to vaccine production
DNA-based Influenza Vaccine Will Be Made by Protein Sciences, Government Says
The company is in late stage trials for a seasonal flu vaccine called Flublok. it plans to be making a swine flu vaccine in five weeks at its pilot production plant, CEO Daniel Adams has said.
Tiny Protein Sciences, Meriden, CT, which is now hiring scientists, joins the ranks of vaccine makers Sanofi-Pasteur, Glaxo and Novartis, which are making seasonal and swine flu vaccines for the government.
These manufacturers still grow vaccine in egg cells, a 50-year old process that takes about five months. Novartis has produced some swine flu vaccine using a mammalian cell-based technique that insiders say is not as productive as DNA technology, although Novartis' approach shaves time off the hen-based method.
Known as recombinant influenza vaccine, the technique Protein Science uses involves extracting a gene from a flu virus and placing it into an insect virus called baculovirus, whose DNA can be quickly cloned.
In addition to ramping up commercial production faster than the egg-growing (or mammalian cell methods), the cloning technology also allows cells to be frozen and stored indefinitely, HHS says.
If Protein Sciences' technology pans out, the contract with HHS could be extended up to five years at a total cost of approximately $147 million, HHS says.
"The technology has advanced in recent years to a point that we believe [DNA-based technology] could help meet a surge in demand for vaccine for seasonal and pandemic flu," Secretary Sebelius said. "We want to use the technology to help our nation respond to emerging infectious diseases."
HHS notes, "if this new technology is demonstrated to be safe and effective and the FDA licenses the new technology for flu vaccines, the contract requires the company to ...provide a finished vaccine within 12 weeks of pandemic onset and to produce at least 50 million doses of pandemic flu vaccine within six months of pandemic onset."
Source: HHS
Read DOTmed's coverage of this important topic:
Novartis First to Make H1N1 Vaccine Using New Cell Technology
http://www.dotmed.com/news/story/9338/
WHO Declares Swine Flu Pandemic
http://www.dotmed.com/news/story/9330/
Flu Slowing in Most Parts of U.S; Vaccine Makers Get $1 Billion
http://www.dotmed.com/news/story/9198/
Swine Flu Virus Update--Where We Stand and How We Got Here
http://www.dotmed.com/news/story/9020/
Delicate Balance of Life on Earth Revealed in Current Flu Spread
http://www.dotmed.com/news/story/9017/
CDC Must Decide Whether to Ramp up New Flu Vaccine
http://www.dotmed.com/news/story/8975/
Race to Find a Flu Vaccine Is On; Flu Remedies Profit
http://www.dotmed.com/news/story/8964/
All Bets Are on Drug Stocks; Government Has Ample Supply
http://www.dotmed.com/news/story/8922
Interested in Medical Industry News?
Subscribe to DOTmed's weekly news email and always be informed.
Click here, it takes just 30 seconds.
|
Please Send us your Comments. |
|
|
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2009 DOTmed.com, Inc.
ALL RIGHTS RESERVED
